Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 7, 2011 - Issue 2
Submit an article Journal homepage
197
Views
19
CrossRef citations to date
0
Altmetric
Review

α1-antitrypsin deficiency and inflammation

Ugo I Ekeowa Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Cambridge, CB2 0XY, UK; Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Cambridge, CB2 0XY, UK
,
Stefan J Marciniak Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Cambridge, CB2 0XY, UK; Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Cambridge, CB2 0XY, UK
&
David A Lomas Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/MRC Building, Cambridge, CB2 0XY, UK;[email protected]
Pages 243-252 | Published online: 10 Jan 2014

References

  • Perlmutter DH, Cole FS, Kilbridge P, Rossing TH, Colten HR. Expression of α1-proteinase inhibitor gene in human monocytes and macrophages. Proc. Natl Acad. Sci. USA82(3), 795–799 (1995).
  • Cichy J, Potempa J, Travis J. Biosynthesis of α1-proteinase inhibitor by human lung-derived epithelial cells. J. Biol. Chem.272(13), 8250–8255 (1997).
  • Silverman GA, Bird PI, Carrell RW et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition novel functions and a revised nomenclature. J. Biol. Chem.276(36), 33293–33296 (2001).
  • Lomas DA, Belorgey D, Mallya M et al. Molecular mousetraps and the serpinopathies. Biochem. Soc. Trans.33(Pt 2), 321–330 (2005).
  • Blanco I, Bustillo EF, Rodriguez C. Distribution of α1-antitrypsin PI*S and PI*Z frequencies in countries outside Europe: a metaanalysis. Clin. Genet.60(6), 431–441 (2001).
  • Sveger T. The natural history of liver disease in α1-antitrypsin deficient children. Acta. Paed. Scand.77(6), 847–851 (1988).
  • Hodges R, Millward-Sadler GH, Path MRC, Barbatis C, Wright R, Phil D. Heterozygous MZ α1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N. Engl. J. Med.304(10), 557–560 (1981).
  • Eigenbrodt ML, McCashland TM, Dy RM, Clark J, Galati J. Heterogenous α1-antitrypsin phenotypes in patients with end stage liver disease. Am. J. Gastroenterol.92(4), 602–607 (1997).
  • Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK. Increased risk of chronic liver failure in adults with heterozygous α1-antitrypsin deficiency. Hepatology28(4), 1058–1063 (1998).
  • Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z α1-antitrypsin accumulation in the liver. Nature357(6379), 605–607 (1992).
  • Mahadeva R, Dafforn TR, Carrell RW, Lomas DA. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerisation: implications for the prevention of Z α1-antitrypsin related cirrhosis. J. Biol. Chem.277(9), 6771–6774 (2002).
  • Tsutsui Y, Kuri B, Sengupta T, Wintrode PL. The structural basis of serpin polymerization studied by hydrogen/deuterium exchange and mass spectrometry. J. Biol. Chem.283(45), 30804–30811 (2008).
  • Yamasaki M, Li W, Johnson DJ, Huntington JA. Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature455(7217), 1255–1258 (2008).
  • Mahadeva R, Chang WSW, Dafforn T et al. Heteropolymerisation of S, I and Z α1-antitrypsin and liver cirrhosis. J. Clin. Invest.103(7), 999–1006 (1999).
  • Dafforn TR, Mahadeva R, Elliott PR, Sivasothy P, Lomas DA. A kinetic mechanism for the polymerization of α1-antitrypsin. J. Biol. Chem.274(14), 9648–9555 (1999).
  • Blanco I, Fernandez-Bustillo E, de Serres FJ, Alkassam D, Rodriguez Menendez C. PI*S and PI*Z α1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain. Med. Clin. (Barc.)123(20), 761–765 (2004).
  • Teckman JH, Perlmutter DH. Retention of mutant α1-antitrypsin Z in the endoplasmic reticulum is associated with an autophagic response. Am. J. Physiol. Gastrointest. Liver Physiol.279(5), G961–G974 (2000).
  • Elliot PR, Stein PE, Bilton D, Carrell RW, Lomas DA. Structural explanation for the deficiency of S α1-antitrypsin. Nat. Struct. Biol.3(11), 910–911 (1996).
  • Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in α1-antitrypsin deficiency. N. Engl. J. Med.314(12), 736–739 (1986).
  • Pan S, Huang L, McPherson J et al. Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in α1-antitrypsin deficiency. Hepatology50(1), 275–281 (2009).
  • Chappell S, Hadzic N, Stockley R, Guetta-Baranes T, Morgan K, Kalsheker N. A polymorphism of the α1-antitrypsin gene represents a risk factor for liver disease. Hepatology47(1), 127–132 (2008).
  • Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter DH. A lag in intracellular degradation of mutant α1-antitrypsin correlates with liver disease phenotype in homozygous PiZZ α1-antitrypsin deficiency. Proc. Natl Acad. Sci. USA91(19), 9014–9018 (1994).
  • Perlmutter DH. Liver injury in α1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J. Clin. Invest.110(11), 1579–1583 (2002).
  • Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest.115(10), 2656–2664 (2005).
  • Marciniak SJ, Ron D. Endoplasmic reticulum stress signaling in disease. Physiol. Rev.86(4), 1133–1149 (2006).
  • Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol.8(7), 519–529 (2007).
  • Graham KS, Le A, Sifers RN. Accumulation of the insoluble PiZ variant of human α1-antitrypsin within the hepatic endoplasmic reticulum does not elevate the steady-state level of grp78/BiP. J. Biol. Chem.265(33), 20463–20468 (1990).
  • Hidvegi T, Schmidt BZ, Hale P, Perlmutter DH. Accumulation of mutant α1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NF-κB, and BAP31 but not the unfolded protein response. J. Biol. Chem.280(47), 39002–39015 (2005).
  • Davies MJ, Lomas DA. The molecular aetiology of the serpinopathies. Int. J. Biochem. Cell Biol.40(6–7), 1273–1286 (2008).
  • Kamimoto T, Shoji S, Mizushima N et al. Intracellular inclusions containing mutant α1-antitrypsin Z are propagated in the absence of autophagic activity. J. Biol. Chem.281(7), 4467–4476 (2006).
  • Kroeger H, Miranda E, Macleod I et al. Endoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins. J. Biol. Chem.284(34), 22793–22802 (2009).
  • Kruse KB, Brodsky JL, McCracken AA. Characterization of an ERAD gene as VPS30/ATG6 reveal two alternative and functionally distinct quality control pathways: one for soluble Z variant of human α1-proteinase inhibitor (A1PiZ) and another for aggregates of A1PiZ. Mol. Biol. Cell17(1), 203–212 (2006).
  • Kruse KB, Dear A, Kaltenbrun ER et al. Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum associated protein degradation and autophagy: an explanation of liver disease. Am. J. Pathol.168(4), 1299–1308 (2006).
  • Hidvegi T, Ewing M, Hale P et al. An autophagy-enhancing drug promotes degradation of mutant α1-antitrypsin Z and reduces hepatic fibrosis. Science329(5988), 229–232 (2010).
  • Terman A, Brunk UT. Aging as a catabolic malfunction. Int. J. Biochem. Cell Biol.36(12), 2365–2375 (2004).
  • Davies MJ, Miranda E, Kaufman RJ, Marciniak SJ, Lomas DA. Neuroserpin polymers activate NF-κB by a calcium-signaling pathway that is independent of the unfolded protein response. J. Biol. Chem.284(27), 18202–18209 (2008).
  • Pahl HL, Baeuerle PA. The ER-overload response: activation of NF-κB. Trends Biochem. Sci.22(2), 63–67 (1997).
  • Roach JC, Glusman G, Rowen L et al. The evolution of vertebrate Toll-like receptors. Proc. Natl Acad. Sci. USA102(27), 9577–9582 (2005).
  • Perlmutter DH. Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in α1-antitrypsin deficiency. Cell Death Differ.16(1), 39–45 (2009).
  • Lindblad D, Blomenkamp K, Teckman J. α1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model. Hepatology46(4), 1228–1235 (2007).
  • Teckman JH, An JK, Blomenkamp K, Schmidt B, Perlmutter D. Mitochondrial autophagy an injury in the liver in α1-antitrypsin deficiency. Am. J. Physiol. Gastrointest. Liver Physiol.286(5), G851–G862 (2004).
  • Goetz JG, Nabi IR. Interaction of the smooth endoplasmic reticulum and mitochondria. Biochem. Soc. Trans.34(Pt 3), 370–373 (2006).
  • Egger L, Madden DT, Rhême C, Rao RV, Bredesen DE. Endoplasmic reticulum stress-induced cell death mediated by the proteasome. Cell Death Differ.14(6), 1172–1180 (2007).
  • Lawless MW, Greene CM, Mulgrew A et al. Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z α1-antitrypsin deficiency. J. Immunol.172(9), 5722–5726 (2004).
  • MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc.2(4), 258–266 (2005).
  • Houghton AM, Quintero PA, Perkins DL et al. Elastin fragments drive disease progression in a murine model of emphysema. J. Clin. Invest.116(3), 753–759 (2006).
  • Lomas DA, Evans DL, Stone SR, Chang WSW, Carrell RW. Effect of the Z mutation on the physical and inhibitory properties of α1-antitrypsin. Biochemistry32(2), 500–508 (1993).
  • Shapiro SD. Proteinases in chronic obstructive pulmonary disease. Biochem. Soc. Trans.30(2), 98–102 (2002).
  • Elliott PR, Bilton B, Lomas DA. Lung polymers in Z α1-antitrypsin deficiency-related emphysema. Am. J. Respir. Cell Mol. Biol.18(5), 670–674 (1998).
  • Mahadeva R, Atkinso C, Li Z et al. Polymers of Z α1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am. J. Pathol.166(2), 377–386 (2005).
  • Parmar JS, Mahadeva R, Reed BJ et al. Polymers of α1-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am. J. Respir. Cell Biol.26(6), 723–730 (2002).
  • Mulgrew AT, Taggart CC, Lawless MW et al. Z α1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest125(5), 1952–1957 (2004).
  • Gooptu B, Lomas DA. Polymers and inflammation: disease mechanisms of the serpinopathies. J. Exp. Med.205(7), 1529–1534 (2008).
  • Zhang B, Qu F, Guo W et al. α1-antitrypsin protects β-cells from apoptosis. Diabetes56(5), 1316–1323 (2007).
  • Petrache I, Fijalkowska I, Medler TR et al. α1-antitrypsin inhibits caspase-3 activity preventing lung endothelial cell apoptosis. Am. J. Pathol.169(4), 1155–1166 (2006).
  • Petrache I, Fijalkowska I, Zhen L et al. A novel antiapoptotic role for α1-antitrypsin in the prevention of pulmonary emphysema. Am. J. Respir. Crit. Care Med.173(11), 1222–1228 (2006).
  • Carroll TP, Greene CM, O’Connor CA, Nolan AM, O’Neill SJ, McElvaney NG. Evidence for unfolded protein response activation in monocytes from individuals with α1-antitrypsin deficiency. J. Immunol.184(8), 4538–4546 (2010).
  • Calfon M, Zeng H, Yoneda T et al. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature415(6867), 92–96 (2002).
  • Lomas DA. The selective advantage of α1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med.173(10), 1072–1077 (2006).
  • Malerba M, Ricciardolo F, Radaeli A et al. Neutrophilic inflammation and IL-8 levels in induced sputum of α1-antitrypsin Pi*MZ subjects. Thorax61(2), 129–133 (2006).
  • Zaman MM, Gelrud A, Junaidi O et al. Interleukin 8 secretion from monocytes of subjects heterozygous for the δF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin. Diagn. Lab. Immunol.11(5), 819–824 (2004).
  • Gross B, Grebe M, Wencker M, Stoller JK, Bjursten LM, Janciauskiene S. New findings in PiZZ α1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology218(4), 370–375 (2009).
  • Mahr AD, Neogi T, Merkel PA. Epidemiology of Wegener’s granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin. Exp. Rheumatol.24(2 Suppl. 41), S82–S91 (2006).
  • Ting SM, Toth T, Caskey F. α1-antitrypsin (A1AT) deficiency presenting with IgA nephropathy and nephrotic syndrome: is renal involvement caused by A1AT deposition? Clin. Nephrol.70(2), 159–162 (2008).
  • Blanco I, Canto H, Flores J et al. Long-term augmentation therapy with α1-antitrypsin in an MZ-AAT severe persistent asthma. Monaldi Arch Chest Dis.69(4), 178–182 (2008).
  • Miranda E, Perez J, Ekeowa UI et al. A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with α1-antitrypsin deficiency. Hepatology52(3), 1078–1088 (2010).
  • Segelmark M, Elzouki AN, Wieslander J, Eriksson S. The PiZ gene of α1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int.48(3), 844–850 (1995).
  • Morris HL, Wood AM, Morgan MD et al. α1-antitrypsin polymers prime neutrophils and are proinflammatory. Presented at: American Society of Nephrology Renal Week. Denver, CO, USA, 16–21 November 2010.
  • Renesto P, Si-Tahar M, Moniatte M et al. Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood89(6), 1944–1953 (1997).
  • Padrines M, Wolf M, Walz A, Baggiolini M. Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett.352(2), 231–235 (1994).
  • Coeshott C, Ohnemus C, Pilyavskaya A et al. Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl Acad. Sci. USA96(11), 6261–6266 (1999).
  • Csernok E, Szymkowiak CH, Mistry N, Daha MR, Gross WL, Kekow J. Transforming growth factor-beta (TGF-β) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin. Exp. Immunol.105(1), 104–111 (1996).
  • Miranda E, Romisch K, Lomas DA. Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. J. Biol. Chem.279(27), 28283–28291 (2004).
  • Miranda E, MacLeod I, Davies MJ et al. The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB. Hum. Mol. Genet.17(11), 1527–1539 (2008).
  • Stoller JK, Aboussouan LS. α1-antitrypsin deficiency. Lancet365(9478), 2225–2236 (2005).
  • Stoller JK, Aboussouan LS. α1-antitrypsin deficiency. 5: intravenous augmentation therapy: current understanding. Thorax59(8), 708–712 (2004).
  • Burrows JA, Willis LK, Perlmutter DH. Chemical chaperones mediate increased secretion of mutant α1-antitrypsin Z: a potential pharmacological strategy for prevention of liver injury and emphysema. Proc. Natl Acad. Sci. USA97(4), 1796–1801 (2000).
  • Teckman JH. Lack of effect of oral 4-phenylbutyrate on serum α1-antitrypsin in patients with α-1-antitrypsin deficiency: a preliminary study. J. Pediatr. Gastroenterol. Nutr.39(1), 34–37 (2004).
  • Mallya M, Phillips R, Saldanha SA et al. Small molecules block the polymerization of Z α1-antitrypsin and increase the clearance of intracellular aggregates. J. Med. Chem.50(22), 5357–5363 (2007).
  • Kaushal S, Annamali M, Blomenkam K et al. Rapamycin reduces intrahepatic α1-antitrypsin mutant Z protein polymers and liver injury in a mouse model. Exp. Biol. Med.235(6), 700–709 (2010).
  • Ekeowa UI, Freeke J, Miranda E et al. Defining the mechanism of polymerization in the serpinopathies. Proc. Natl Acad. Sci. USA107(40), 17146–17151 (2010).
  • Lomas DA, Finch JT, Seyama K, Nukiwa T, Carrell RW. α1-antitrypsin Siiyama (Ser53→Phe); further evidence for intracellular loop sheet polymerisation. J. Biol. Chem.268(21), 15333–15335 (1993).
  • Gooptu B, Ekeowa UI, Lomas DA. Mechanisms of emphysema in α1-antitrypsin deficiency: molecular and cellular insights. Eur. Respir. J.34(2), 475–488 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.